When health insurers offer financial incentives through value-based insurance design (VBID), patients have greater likelihood of filling prescriptions for their chronic conditions. However, research hasn't shown a drop in overall medical spending when it comes to VBID.
When health insurers offer financial incentives through value-based insurance design (VBID), patients have greater likelihood of filling prescriptions for their chronic conditions. However, research hasn't shown a drop in overall medical spending when it comes to VBID. Modern Healthcare reports:
Patients are more likely to fill prescriptions that treat costly, chronic diseases when health insurers offer them a financial incentive to do so through value-based insurance design. That's the good news in a research review just published by the journal Health Affairs.
The bad news? Research has yet to show any significant drop in overall medical spending, wrote authors of the review, which examined prior studies of value-based design and proper medication use.
This isn't necessarily surprising given that experts say it often takes time for improved drug treatment and care to stabilize patients' chronic conditions and reduce their healthcare costs. And by then the patient may have switched insurers.
Read the full story here: http://bit.ly/1aW6J51
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Early Involvement Critical in Treating Immunotherapy-Induced Overlap Syndrome
April 19th 2024A series of case studies reveals the importance of early diagnosis and involvement of special teams of clinicians when dealing with potential cases of overlap syndrome, which encompasses myocarditis, myasthenia gravis, and immune checkpoint inhibitor–related myositis.
Read More
Making Giant Strides in Maternity Health Through Baby Steps
April 9th 2024To help celebrate and recognize National Minority Health Month, we are kicking off a special month-long podcast series with our strategic alliance partner, UPMC Health Plan. Welcome to our first episode, which is all about the Baby Steps Maternity Program and its mission to support women throughout every step of their pregnancy journey.
Listen